{"data":{"id":168,"lang":"en","title":"OpenAI Invests in CEO Sam Altman's Brain-Computer Interface Startup Merge Labs at $850M Valuation","summary":"OpenAI makes largest investment in $252M seed round for Merge Labs, Altman's brain-computer interface startup valued at $850M.","category":"technology","category_label":"Technology","published_at":"2026-01-25T13:34:55Z","updated_at":"2026-01-25T13:34:55Z","url":"https://techtools.cz/tools/news/article/168-openai-invests-in-ceo-sam-altman-s-brain-computer-interface-startup-merge-labs","api_url":"https://techtools.cz/news-api/v1/articles/168?lang=en","markdown_url":"https://techtools.cz/news-api/v1/articles/168.md?lang=en","image_url":"https://techcrunch.com/wp-content/uploads/2026/01/GettyImages-2255262571.jpg","word_count":156,"reading_time_minutes":1,"sources":[{"url":"https://techcrunch.com/2026/01/15/openai-invests-in-sam-altmans-brain-computer-interface-startup-merge-labs/","domain":"techcrunch.com"},{"url":"https://www.theregister.com/2026/01/16/openai_merge_labs_brain_interface_investment","domain":"theregister.com"}],"translation":null,"content":"OpenAI has made its largest investment in Merge Labs, a brain-computer interface startup co-founded by its own CEO Sam Altman. The $252 million seed round values the company at $850 million, with Bain Capital leading and Valve co-founder Gabe Newell also participating.\n\nMerge Labs aims to develop non-invasive BCIs using molecules instead of electrodes, with ultrasound for data transmission—avoiding surgical implants entirely. \"We envision future BCIs that are equal parts biology, device, and AI in a form factor that we ourselves want to use,\" the company stated. Co-founders include neuroscience researchers Mikhail Shapiro, Tyson Aflalo, and Sumner Norman, alongside tech entrepreneurs Alex Blania and Sandro Herbig.\n\nThe funding puts Merge among the best-capitalized BCI startups, second only to Neuralink's $650 million Series E at $9 billion valuation. However, Merge concedes its technology may take \"decades rather than years\" to realize. The investment raises conflict-of-interest questions given Altman's dual role as OpenAI CEO and Merge co-founder."}}